[Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors].
D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D002421:Caudate Nucleus / Q000378:metabolism; D018492:Dopamine Antagonists; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005116:Extrapyramidal Tracts / Q000187:drug effects*; D007490:Iproniazid / Q000494:pharmacology; D008854:Microscopy, Electron; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D013378:Substantia Nigra / Q000378:metabolism; D013569:Synapses / Q000187:drug effects
D002395:Catecholamines; D018492:Dopamine Antagonists; D008996:Monoamine Oxidase Inhibitors; D012110:Reserpine; D007490:Iproniazid; D009638:Norepinephrine; D004837:Epinephrine
Submikroskopische Catecholaminspeicher als Angriffspunkte der Psychopharmaka Reserpin und Mono-Amino-Oxydase-Hemmer.